Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Post Concussive Syndrome Polypharmacy
NCT06333990Phase 3Recruiting
- Sponsor
- Foundation for Advancing Veterans' Health Research
- Start
- Jul 2024
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in Post-concussion syndrome (PCS), post-traumatic stress disorder (PTSD), sponsored by Foundation for Advancing Veterans' Health Research. Started Jul 2024; status: recruiting.
02
Drugs
quetiapine
03
Conditions
Post-concussion syndrome (PCS)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06333990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06333990.